Results from a large study on the outcomes of 427 pregnant women and their babies during the first wave of the COVID-19 pandemic gave reassurance that pregnant women were at no greater risk of severe illness than other women.
NIHR-funded researchers show that an internet-based weight-loss programme with brief support from a nurse can help people with obesity lose weight.
A new approach to pre-donation screening was introduced across the whole national blood service as a result of NIHR research, saving around 30,000 people from avoidable anaemia and potential iron deficiency every year.
NIHR-funded researchers are working with communities on three continents to improve the patient journey and reduce stigma for people with cutaneous leishmaniasis.
Midwife-led models of continuity of care improve outcomes for pregnant women. Working with hospital trusts, managers and frontline staff has enabled the development of a new care pathway and guidelines to implement it in a sustainable way.
An online diabetes education tool has been shown to help patients control blood sugar levels and is now being considered for roll out across the country by NHS England.
NIHR-funded research has developed ‘smart glasses’ that have been developed to improve sight using real-time image enhancement software.
A treatment for children with a rare form of childhood dementia has made a dramatic difference to their outcomes. The UK arm of the drug trial took place at the NIHR Great Ormond Street Hospital Biomedical Research Centre where today 19 patients receive regular therapy.
Exercise programmes reduce falls among the over 65s by almost a quarter.
Public engagement from the outset of research helped NIHR researchers develop a website to explain complex and sensitive children’s heart surgery data to the public. The lessons learned led to a best practice guide for researchers involving patients and the public in research.
Faced with a growing burden of liver disease, researchers at the NIHR Nottingham Biomedical Research Centre reimagined the way that patients could be diagnosed in community settings. Their pathway has been tested and is being taken up by the NHS to the benefit of patients.
A blood test has been shown to speed up diagnosis of pre-eclampsia and help determine which women are at most risk of developing severe complications. The test is now widely available across the NHS.
A new approach to the prevention of challenging behaviour among people with learning disabilities in social care settings has reduced challenging behaviour by two thirds and been rolled out across 800 residential settings.
Dr Pearse Keane, NIHR Clinician Scientist, is responsible for a research collaboration that has the potential to save sight.
A non-invasive test for prostate cancer gives a clearer picture of clinically relevant cancer, ruling out cancer in many cases and ensuring more accurate biopsy for those who need it
An electronic frailty index developed by NIHR-funded researchers has been rolled out in primary care nationally.
Screening women for breast cancer in their forties reduces their chance of dying from breast cancer by 25% in the first 10 years of screening.
NIHR-funded researchers from the University of Glasgow evaluated the effectiveness of Football Fans in Training (FFIT) - a programme to help football fans lose weight, feel better and live a healthier lifestyle.
NIHR research finds no evidence of an association between reduced street lighting and night-time road casualties or crime across England and Wales.
The VOICE study looked at how healthcare professionals could improve their knowledge, confidence and skills for communicating with patients with dementia. It has led to the development of an evidence-based communication skills training course.
Research supporting the use of skin-to-skin contact to encourage breastfeeding has global impact.
A set of safety indicators to identify patients at risk of harm from prescribing errors, along with a pharmacist-led IT-based intervention, are reducing clinically important medication errors.
NIHR-funded researchers find an 80% reduction in harmful second-hand smoke concentrations following smoking ban in Scotland's prisons.
New drug helps medical teams make the best decisions to manage critically ill patients.
The MOAM trial is the first ever large-scale trial of treatment for offenders with antisocial personality disorder. It provides an excellent demonstration of the impact of patient and public involvement in research.
